相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Clinical Utility Index as a Practical Multiattribute Approach to Drug Development Decisions
B. Poland et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans
Nirmala Raghavan et al.
DRUG METABOLISM AND DISPOSITION (2009)
Concepts and Challenges in Quantitative Pharmacology and Model-Based Drug Development
Liping Zhang et al.
AAPS JOURNAL (2008)
Leveraging prior quantitative knowledge to guide drug development decisions and regulatory science recommendations: Impact of FDA pharmacometrics during 2004-2006
Yaning Wang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparin
Takeshi Fuji et al.
JOURNAL OF ORTHOPAEDIC SCIENCE (2008)
Venous thromboembolism in elective operations: Balancing the choices
Motaz Qadan et al.
SURGERY (2008)
The efficacy and safety of apixaban, an oral, direct factor Xa inhibitor, as thromboprophylaxis in patients following total knee replacement
M. R. Lassen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Model-based drug development
R. L. Lalonde et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Impact of pharmacometric reviews on new drug approval and labeling decisions - a survey of 31 new drug applications submitted between 2005 and 2006
V. A. Bhattaram et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Risk factors and clinical impact of postoperative symptomatic venous thromboembolism
Chethan Gangireddy et al.
JOURNAL OF VASCULAR SURGERY (2007)
A multi-dimensional model of clinical utility
Andrew Smart
INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE (2006)
Novel factor Xa inhibitors for prevention and treatment of thromboembolic diseases
Dagmar Kubitza et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2006)
Development and evaluation of a population pharmacokinetic-pharmacodynamic model of darbepoetin alfa in patients with nonmyeloid malignancies undergoing multicycle chemotherapy
Balaji Agoram et al.
AAPS JOURNAL (2006)
Clinical and economic consequences of bleeding following major orthopedic surgery
M Vera-Llonch et al.
THROMBOSIS RESEARCH (2006)
Impact of pharmacometrics on drug approval and labeling decisions: A survey of 42 new drug applications
VA Bhattaram et al.
AAPS JOURNAL (2005)
Heparin and low-molecular-weight heparin - The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
J Hirsh et al.
CHEST (2004)
Optimizing dose selection with modeling and simulation: Application to the vasopeptidase inhibitor M100240
M Pfister et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Prospective evaluation of a D-optimal designed population pharmacokinetic study
B Green et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2003)
分享论文
